Also, vasoactive intestinal peptide has been reported to induce neuroendocrine differentiation in the LNCaP prostate cancer cells and the orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation [169,170]. The gene discussed is HCRTR1; the disease is Familial prostate cancer.